Citations

Clear

414 citation(s) found for "Collins, S".

Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses
Flerlage, Jamie E. , Eichenauer, Dennis A. , Fuchs, Michael, Hartmann, Sylvia , Eich, Hans Theodor, Savage, Kerry J. , Skinnider, Brian, Akhtar, Saad , Steiner, R., Milgrom, Sarah A., Vega, Francisco, Alomari, Mohammed , Zhang, Xiaoyin , Collins, Graham P., Advani, Ranjana H, Kumar, Priyadarshini , Wirth, Andrew, Tsang, Richard, Smith, SD, Hendrickson, Peter G. , Hopkins, David, McKay, Pamela, Ng, Andrea K. , Koenig, Julie L. , Sakthivel, Gukan, Baron, Jonathan A, Roberts, Kenneth B. , Gao, Sarah, Alkendi, Jalila , Rahbi, Nasser Al, Balogh, Alexander George, Ricardi, Umberto, Sridhar, Akshay, Torka, Pallawi , Specht, Lena , Silva, Ravi De , Shah, Nimish, Osborne, Wendy , Henry, Michael, Chang, Isabela , Halperin, Daniel, Miall, Fiona , Brady, J.L. , Mikhaeel, G., Brennan, Bernadette , Penn, Anthony, Reeves, Marie, Terezakis, Stephanie A, Pepa, R Della, Picardi, Marco, Kirova, Youlia, Fergusson, Paige, Hawkes, Eliza A. , Lee, Denise , Ku, Matthew , Hamad, Nada, Mutsando, Howard , Tedjaseputra, Aditya , Gilbertson, Michael, Marconi, Tamara , Viiala, Nicholas , Palese, Monica , Kelly, Kara M, Borchmann, P, Hoppe, Richard T. , Advani, Ranjana H. , Hopkins, David , Baron, Jonathan , Vega, Francisco , Kumar, Priyadarshini , Dickinson, Michael , Smith, Sonali M , McKay, Pamela , Koenig, Julie , Casulo, Carla , Al Kendi, Jalila , Levis, Mario , Torka, Pallawi , Specht, Lena , De Silva, Ravindu , Pickard, Keir , Smith, Christine M , Brady, Jessica , Senchenko, Maria Anatolevna , Volchkov, Egor Vasilevich , Hoppe, Bradford S , Hawkes, Eliza , Lee, Denise , Doo, Nicole Wong , Barraclough, Allison , Cheah, Chan Yoon , Salvaris, Ross , Ku, Matthew , Hamad, Nada , Tedjaseputra, Aditya , Shankar, Ananth , Maurer, Matthew , Natkunam, Yasodha , Hoppe, Richard T , Binkley, Michael Sargent , Savage, Kerry J , Advani, Ranjana H , Hopkins, David , Baron, Jonathan , Eichenauer, Dennis A , Flerlage, Jamie E , Fuchs, Michael, Eich, Hans Theodor, Hodgson, David C. , Skinnider, Brian, Rauf, M. Shahzad , Maghfoor, Irfan , Pinnix, Chelsea C. , Alomari, Mohammed, Collins, Graham P. , Dickinson, Michael , Tsang, Richard , Prica, Anca A. , Major, Ajay , Kelsey, Chris R. , Constine, Louis S , Casulo, Carla , Plastaras, John Peter , Balogh, Alexander G., Levis, Mario , Ricardi, Umberto , Sridhar, Akshay, Shah, Nimish , Pickard, Keir , Blazin, Lindsay , Henry, Michael, Smith, Christine M. , Hoppe, Bradford S. , Talaulikar, Dipti , Pepa, Roberta Della , Picardi, Marco , Kirova, Youlia , Northend, Michael , Doo, Nicole Wong , Barraclough, Allison , Opat, Stephen , Cheah, Chan Y. , Hamad, Nada , Gilbertson, Michael , Maurer, Matthew J. , Natkunam, Yasodha , Kelly, Kara M. , Borchmann, Peter , Binkley, Michael S.

Mayo Clinic

Blood Advances | April 14, 2026 | Volume: 10 | Issue: 15 | Pages: 5338-5347

10.1182/bloodadvances.2026020012 | PMID 41979337 Get It

Abstract We evaluated outcomes by management type for patients with stage IA nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in the Global NLPHL One Working Group retrospective database of 2243 patients with stages I to IV disease diagnosed from 1992 to 2021 at 38 international institutions. A total of 779 patients had stage IA disease with median age of 35 years (range, 3-89) and median follow-up of 6.1 years. The 6-year progression-free survival (PFS) and overall survival were 86.3% and 97.7%, respectively. Outcomes were analyzed for the 2 groups: complete resection and unresected disease. Patients with a complete resection and observation alone (n = 99) had a 6-year PFS of 65.5% vs 90.5% for those who received radiotherapy (RT) (n = 53). Patients with unresected disease (n = 627; 80.5%) had a 6-year PFS of 62.0% for rituximab alone (n = 31), 89.6% for RT alone (n = 325), 76.8% for ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) alone (n = 40), and 94.3% for ABVD plus RT (n = 130). A total of 127 patients relapsed (16.3%), of which 25 (19.7%) had transformation. Our analysis suggests the following: (1) RT improves the PFS in patients with completely resected disease; (2) rituximab or ABVD alone does not appear to achieve a durable response; and (3) chemotherapy was not observed to add additional PFS benefit when used in combination with RT. Thus, for stage IA NLPHL, RT alone is likely sufficient for definitive treatment.
Educating Anesthesiology Residents and Their Support Persons to Improve Understanding and Increase Wellness: A Multisite Study
Martinelli, Susan M. , Tran, Thanh N. , Canter, Courtney , Hu, Di , Isaak, Robert S., Mulaikal, Teresa A., Ladlie, Beth L., Jain, Ankit , Willie, Chelsea, Stahl, David, Carter, Tekuila R., Zisblatt, Lara , Hoefnagel, A. L. , Marshall, Julie , Collins, Stephen, Martin, TD, Stahl, David L. , Ladlie, Beth, Carter, Tekuila R , Marshall, Julie M , Isaak, Robert S. , Afroze, Farzana, Jain, Ankit, Keneally, Ryan J. , Chen, Fengqian

Mayo Clinic

Anesthesia & Analgesia | April 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1213/ane.0000000000008030 | PMID 41962000 Get It

BACKGROUND: Burnout remains prevalent among anesthesiology residents. Contributing workplace factors include limited control over scheduling, unpredictable hours, critical patient care needs, and other residency challenges. The Family Anesthesia Experience (FAX) is a program designed to educate residents and their support persons on wellness and residency demands. The focus of this multisite study was to evaluate the impact of FAX on first year clinical anesthesiology (CA1, ie, PGY2s) residents’ wellness. METHODS: This was a prospective evaluation study involving 15 US anesthesiology residency programs, 13 of which completed FAX. CA1 wellness was evaluated through surveys assessing perceived stress as the primary outcome, with exploratory outcomes including burnout, depression, psychological wellness, and social support. Additionally, changes in support persons’ understanding and knowledge of residency demands were tracked over time. The study included a historical control group of 302 CA1s (2019-2021) who did not participate in FAX, and an intervention group of 88 CA1s that participated in FAX (2021-2022). Statistical analyses compared changes in metrics between groups using linear mixed models and generalized linear models. RESULTS: Significant reductions in perceived stress were observed in the intervention group at 6 months post-FAX (mean change = –2.14, 95% CI, –3.95 to –0.34; P = .021, effect size = 0.58) relative to the control group, but there was no sustained difference at 12 months. Compared to the control support persons, intervention support persons reported increased understanding of residency demands, with significant improvements at 6 (mean change = 2.80, 95% CI, 1.12–4.48; P = .001, effect size = 0.77) and 12 (mean change = 2.59, 95% CI, 0.12–5.05; P = .039, effect size = 0.71) months. Improvement in support persons’ understanding did not predict changes in CA1 wellness outcomes. First generation physician residents reported lower family support at baseline but showed significant improvements in family support at 6 months (mean change = 3.05 points; 95% CI, 0.25–5.84; P = .033; effect size = 1.23) compared to their non first generation peers. CONCLUSIONS: FAX participation was associated with reduced perceived stress in residents up to 6 months post-intervention. First generation physicians experienced greater improvements in perceived family support compared to their non first generation peers. Our findings suggest that resident wellness may be enhanced by engaging both residents and their support persons in an educational wellness program that outlines the professional expectations and demands of anesthesiology residency training.
Brain network analysis in Alzheimer’s disease and mild cognitive impairment using high-density diffuse optical tomography
Butters, Emilia , Collins-Jones, Liam , Mesquita, Rickson C. , Acharya, Deepshikha , McKiernan, Elizabeth , Laurell, Axel AS, Low, Audrey , Srinivasan, Sruthi , O’Brien, John, Su, Li , Laurell, Axel Anders Stefan , Low, Audrey , O'Brien, John Tiernan , Su, Li , Bale, Gemma M.

Mayo Clinic

Imaging Neuroscience | March 26, 2026 | Volume: 4 | Issue: No issue available | Pages: No page available

10.1162/imag.a.1208 | PMID 42052506 Get It

Abstract Dementia is associated with altered resting-state connectivity, measures of which could aid in its early detection and monitoring. High-density diffuse optical tomography (HD-DOT) is well suited to detect these alterations at scale due to its numerous practical advantages, but it has not yet been applied to dementia. In this study, we investigated resting-state functional connectivity across the prefrontal cortex in individuals with mild cognitive impairment (MCI, n = 22), Alzheimer’s disease (AD, n = 21), and in healthy controls (n = 22). A graph theoretical approach was taken to characterise both global and local patterns of prefrontal connectivity over a 5-minute resting period. We found that individuals with MCI exhibited denser and stronger networks with shorter path lengths, which normalised in AD, accompanied by a redistribution of network hubs that were less stable. These results perhaps reflect the recruitment of additional connections in the early stages of pathology to maintain short-term network stability, which is ultimately associated with less efficient and more fragmented network organisation in later stages. Following the demonstration of HD-DOT’s capacity to detect differences between healthy ageing and AD-type cognitive impairment, this work opens up new possibilities for the use of optical imaging in the study of this clinical population and HD-DOT’s potential for scalable clinical use.
1716: POCUS COURSES CAN LEAD TO MEANINGFUL DIFFERENCE IN APPLICATION: SECONDARY ANALYSIS FROM CUSP SURVEY
Hessinger, Justin, Odhiambo, Collins, Bhowmick, Kaushik , Duvvuri, Padmaraj , Guru, Pramod, Keyrouz, Salah, Sinha, Sharmili , White, Candice, Odhiambo, Collins , Bhargava, Vidit , Bhowmick, Kaushik, Guru, Pramod , Tripathi, Sandeep

Mayo Clinic

Critical Care Medicine | March 24, 2026 | Volume: 54 | Issue: 3S | Pages: No page available

10.1097/01.ccm.0001188860.91388.1d Get It

Chronic graft versus host disease in upper limb: Calling upper limb rehabilitation specialists for improving outcomes in patients
Mohammed, Jaleel , Couthard, Caroline, Alghamdi, Ahmed , Ogbeivor, Collins , Hashmi, S., Mohammed, Jaleel A , Couthard, Caroline, AlGhamdi, Ahmed, Hashmi, Shahrukh K.

Mayo Clinic

Clinical Hematology International | March 11, 2026 | Volume: 8 | Issue: 1 | Pages: No page available

10.46989/001c.158500 | PMID 41835915 Get It

Background Chronic graft versus host disease (cGVHD) is a complex post-transplant complication resulting in varying degrees of musculoskeletal (MSK) manifestations, including sclerosis-type skin conditions, fasciitis, and osteopenia, avascular necrosis affecting the shoulder, elbow and hands apart from other joints of the body. A large proportion of these can often miss out on the expertise of upper limb therapists. Study Objectives This paper aims to outline upper limb cGVHD manifestations to raise awareness among upper limb physiotherapists and rehabilitation specialists, so that patients can receive more focused, optimal care. Methods An electronic search was conducted across a wide database covering the period from 1990 to 2025. Further manual search used Google Scholar to help identify relevant articles. Boolean operators ‘AND’ and ‘OR’ combined keywords such as chronic graft versus host disease, acute graft versus host disease, allogenic hematopoietic stem cell transplantation, hematopoietic cell transplantation, stem cell transplant, bone marrow transplant, physiotherapy, upper limb specialist, musculoskeletal, fasciitis, and scleroderma. Results A total of 4,393 titles were screened against the pre-set inclusion and exclusion criteria, and only 3 articles were found to be suitable for this narrative review. All 3 articles were case studies of upper limb cGVHD and rehabilitation reporting positive outcomes on patients’ upper and lower limb range of motion, function, and quality of life (QoL). Conclusion cGVHD can cause various MSK issues, especially in the upper limbs. It is important to collaborate with upper limb physiotherapy and occupational therapy experts to improve awareness and patient outcomes.
Critical Care Ultrasound Practice ( CUSP ) Survey: An International Survey of Ultrasound Practice Among Critical Care Practitioners
Odhiambo, Collins , Bhargava, Vidit , Bhomick, Kaushik, Duvvuri, Padmaraj D., Keyrouz, Salah , Sinha, Sharmili , White, Candice, Odhiambo, Collins , Bhargava, Vidit , Tripathi, Sandeep , Duvvuri, Padmaraj , Guru, Pramod

Mayo Clinic

Australasian Journal of Ultrasound in Medicine | March 9, 2026 | Volume: 29 | Issue: 2 | Pages: No page available

10.1002/ajum.70039 | PMID 41809461 Get It

ABSTRACT Objective To describe the practice patterns of point‐of‐care ultrasound (POCUS) and compare its usage across subgroups (adult vs. paediatric practitioners, physicians vs. nurse practitioners [NPs], high income [HI] vs. low and middle ‐income [LMI] countries). Methods Survey distributed via the Society of Critical Care Medicine in May–June 2024. Respondents reported the percentage of eligible patients in the past year for whom POCUS was used for vascular access and diagnostic purposes. Responses (0%, < 25%, 25%–50%, 50%–75%, > 75%) were converted into binary categories (> 50% use) and compared across subgroups using logistic regression. Results The survey was completed by 503 respondents from 39 countries (6% response rate): 77.7% from HI countries, 20.9% paediatric practitioners and 18.3% Nurse Practitioner (NPs)/Physician assistants (PAs). POCUS was commonly used for vascular access, and similar usage was found among NP/PAs, physicians, and adult and paediatric practitioners. Practitioners from LMI countries were less likely to use POCUS for vascular access. Basic diagnostic applications, such as assessing pleural effusion (72.5%) and left ventricular function (69.2%), were more commonly used than advanced applications like pulmonary artery pressure measurement (22%). Physicians were more likely than NPs (for some indications), and adult practitioners were more likely than paediatric practitioners (for most indications) to use POCUS for diagnostic purposes. Practitioners in LMI countries reported higher use of diagnostic applications than practitioners in HI countries. Conclusions POCUS is widely adopted in critical care but is less accepted for diagnostic use among paediatric practitioners and NP/PAs. Diagnostic utilisation is higher in LMI countries, while procedural use is lower. Impact Statement Point‐of‐care ultrasound (POCUS) is increasingly used in intensive care units to guide diagnosis and procedures. Despite its importance, little is known about how consistently it is used by different types of clinicians around the world. This international survey of critical care practitioners from 39 countries shows that POCUS is widely used, particularly for procedures, but diagnostic use remains uneven. Paediatric clinicians and advanced practice providers report lower diagnostic use, while clinicians in low‐ and middle‐income countries report higher diagnostic adoption. These findings highlight opportunities to improve access to training and support broader, more equitable use of POCUS in critical care.
Integrative screening identifies functional variants and VNTRs underlying GWAS signals at the 5p15.33 multi-cancer susceptibility locus
O’Brien, Aidan , Kong, Hyunkyung, Patel, Harsh , Ho, Michelle , Patel, Minal, Zhong, Jun , Xu, Mai, Papenberg, Brenen W. , Connelly, Katelyn E. , Collins, Irene , Hennessey, Rebecca C. , Thakur, Rohit , Sowards, Hayley , Funderburk, Karen, Luong, Thong Minh, Florez-Vargas, Oscar , Myers, Timothy , Jermusyk, Ashley , Gorman, Bryan, Das, Sudipto, (PanScan/PanC4), The Pancreatic Cancer Cohort and Case-Control Consortia, Lan, Qing, Rothman, Nathaniel , McKay, James , Hung, R., Iles, Mark M. , Landi, Maria Teresa , Stolzenberg-Solomon, Rachael Z, Wolpin, Brian M. , Hassan, Manal M. , Antwi, Samuel O. , Lindström, Sara , Stern, Marc-Henri, Andrésson, Þorkell , Shi, Jianxin , Choi, Jiyeon, Brown, Kevin M, Rabe, Kari G. , Patel, Minal B , Hennessey, Rebecca , Luong, Thong , Jones, Kristine , Das, Sudipto , McKay, James , Hung, Rayjean J , Amos, Christopher I , Iles, Mark M , Koutros, Stella , Landi, Maria T , Law, Matthew H , Hassan, Manal M , Klein, Alison P , Orr, Nick , Chanock, Stephen Jacob , Lindstrom, Sara , Hoskins, Jason W , Shi, Jianxin , Prokunina-Olsson, Ludmila , Choi, Jiyeon , Brown, Kevin M , Amundadottir, Laufey , Chaffee, Kari G. , Antwi, Samuel O , Zhong, Jun , Luo, Wen , Lan, Qing , Rothman, Nathaniel , Amos, Christopher I. , Koutros, Stella , Law, Matthew H. , Stolzenberg‐Solomon, Rachael Z. , Klein, Alison P. , Orr, Nick , Hoskins, Jason W. , Stern, Marc‐Henri , Choi, Jiyeon , Ámundadóttir, Laufey T.

Mayo Clinic

No container title available | March 5, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.03.03.26347427 | PMID 41867231 Get It

Abstract Chromosome 5p15.33 harbors several independent association signals which demonstrate antagonistic pleiotropy across cancer types, with causal mechanisms largely unresolved. To identify functional variants and enhancer elements at this locus, we performed statistical fine-mapping followed by massively parallel reporter assays (MPRA) and proliferation based CRISPRi screens. This approach identified eight multi-cancer functional variants (MCFVs) across three GWAS signals. Targeting rs421629 (part of the CLPTM1L signal marked by rs465498) with CRISPRi revealed opposing effects on TERT expression in pancreatic versus lung cancer cells, consistent with the antagonistic pleiotropy observed for this signal. Furthermore, CRISPRi nominated an intronic CLPTM1L variable number tandem repeat (VNTR) as a potent enhancer. Long-read sequencing established VNTR polymorphisms as potential causal variants for the rs465498 signal. We showed that Hippo-pathway transcription factors mediate VNTR enhancer activity in lung and pancreatic cancer cells. Together, these findings indicate that cancer susceptibility at 5p15.33 may be mediated by both SNPs and VNTRs and provide an integrated framework for resolving complex pleiotropic loci.
Pharmacotherapy agents in prevention and treatment of breast cancer-related lymphedema: a systematic scoping review
Lommer, Caroline , Schroeder, Lila, Amato, Caroline, Dhakal, Kerry , Kotian, Caitlin, Quiroga, Dionisia , Paskett, E., Fu, Mei , Collins, Stephanie, King, T. A., McLaughlin, Sarah A. , Myers, Sara P. , Paskett, Electra D. , McAlearney, Ann Scheck

Mayo Clinic

Frontiers in Oncology | March 4, 2026 | Volume: 16 | Issue: No issue available | Pages: No page available

10.3389/fonc.2026.1751628 | PMID 41858365 Get It

Background Breast cancer-related lymphedema (BCRL) is a common and life-long adverse event affecting ~20% of breast cancer survivors. As existing non-pharmacologic management is burdensome, expensive, and variably effective, this systematic scoping review aims to identify pharmacologic and herbal agents for prevention and treatment for BCRL. Methods PubMED, Embase, Web of Science Core collection, and the Cumulative Index to Nursing and Allied Health Literature were searched for studies published in English between 1993 and 2025 that investigated the preventative or therapeutic effect of pharmacologic or herbal agents on BCRL among adult stage I-III breast cancer patients. Studies describing interventions with systemically absorbed anti-inflammatories, anti-thrombotics, anti-coagulants, and blood product components were included. Systematic reviews, protocols for ongoing clinical trials, preclinical and non-human studies, editorials, and studies not exclusive to BCRL were excluded. Three reviewers screened and extracted data between June and August 2025. The primary outcomes of interest were reduction in BCRL incidence or severity. Results Of the 217 articles screened, 37 were included in the final review. After full text review, 13 were excluded for repetitive data, non-English language, or irrelevant outcomes. The 24 studies included in the analysis investigated anti-diabetic, herbal, anti-inflammatory, anti-hypertensive, immunomodulatory, and microbiome modifying agents, and venoactive flavinoid derivates. Three studies explored the role of pharmacologic/herbal agents in BCRL prevention. While thiazolidinediones, anti-hypertensives, and non-steroidal anti-inflammatory drugs (NSAIDs) had no effect on BCRL incidence, glucagon-like peptide-1 receptor agonists (GLP-1 RA) were associated with BCRL prevention. In the 21 studies that assessed the effect of pharmacologic/herbal agents in BCRL treatment, NSAIDs/steroids, anti-hypertensives, microbiome/synbiotic supplements, and doxycycline showed no benefit and data for flavonoid-derived venoactive agents and herbal products were inconsistent. Immune-modulating therapies were associated with improved BCRL signs/symptoms in three studies. Conclusion This systematic scoping review found limited evidence suggesting that GLP-1 RAs may reduce the risk of BCRL and that immunomodulatory agents may improve signs/symptoms of BCRL. Rigorous prospective trials using standardized limb volume/edema, quality-of-life (QoL), and symptom measures and longer follow-up are needed to inform clinical practice aimed at preventing and treating BCRL. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/ , identifier CRD420251055134.
Alignment of large language models in solving medical ethical dilemmas
Sorin, Vera , Glicksberg, Benjamin S., Korfiatis, Panagiotis , Yeow, Mei-Ean, Brandeland, Megan, Nadkarni, Girish N., Klang, Eyal, Klang, Eyal , Collins, Jeremy D. , Glicksberg, Benjamin S. , Yeow, Mei-Ean , Brandeland, Megan , Nadkarni, Girish N.

Mayo Clinic

DIGITAL HEALTH | February 26, 2026 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/20552076261428395 | PMID 41767866 Get It

Background Large language models (LLMs) are entering clinical workflows, yet their alignment with medical-ethical principles is unclear. Objective To evaluate how LLMs reconcile deontological and utilitarian reasoning in medically adapted “Trolley dilemma” scenarios. Methods We tested 14 LLMs, including GPT-o1-preview and DeepSeek-R1-Distill-Llama, using five medically adapted Trolley dilemmas sourced from philosophical and real-world scenarios. Each model generated 10 independent answers per case (overall 700 responses). Responses were forced to “yes” (utilitarian) or “no” (deontological). The primary outcome was the proportion of utilitarian choices. χ 2 tests compared models. Results LLM responses varied. Some models, such as GPT-4 and Gemma, selected the utilitarian option in 20% of cases, while others, like Qwen-2-7B, reached 80% ( p < .001). GPT-o1-preview and DeepSeek-R1-Distill-Llama selected utilitarian responses in 44% and 38% of cases, respectively. Some models selected the consequence-maximizing option in vignettes where doing so required overriding consent or endorsing intentional harm within the scenario framing. Seven of the fourteen models tested recommended impermissible medical actions, including nonconsensual limb amputation, killing a healthy person for organ harvesting, and transferring a patient to hospice against their wishes, in 44 of 700 outputs (6.3 %). Conclusions In this constrained forced-choice stress test, models occasionally endorsed boundary-violating actions within the vignette framing. These results do not generalize to routine clinical decision-making, but motivate further benchmarked evaluation of refusal behavior and boundary constraints in ethically sensitive medical contexts. We must carefully define how these models influence clinical decisions, establish robust ethical guidelines for their use, and ensure that fundamental ethical norms are not compromised.
Understanding Daptomycin Resistance Mechanisms and Treatment Challenges in Enterococcus faecium Infection: A Case Series
Nair-Collins, Sangeeta, Godart, Gabriel A. , Patel, Nipakumari , Yadav, Vidit , Larimore, Kelly , Chitale, Rohit , Durvasula, R, Oring, Justin , Godart, Gabriel , LeGout, Jordan D. , Oring, Justin

Mayo Clinic

Antibiotics | February 26, 2026 | Volume: 15 | Issue: 3 | Pages: 243

10.3390/antibiotics15030243 | PMID 41892405 Get It

Daptomycin-resistant Enterococcus faecium (DRE) poses an increasing therapeutic challenge, particularly in immunocompromised patients and solid organ transplant recipients. Surveillance data from the Centers for Disease Control and Prevention indicate that approximately 6.5% of E. faecium isolates are daptomycin-resistant, underscoring the need for heightened clinical vigilance, particularly for prompt identification and treatment. In this case series, three patients with advanced liver disease, including two status post orthotopic liver transplantation, are described who developed DRE during treatment for bloodstream infection. These cases illustrate the dynamic nature of antimicrobial susceptibility under daptomycin exposure and highlight the contributions of persistent source control issues, intravascular infection, and altered host factors to treatment failure. All patients were successfully managed by escalating to combination therapy with high-dose daptomycin and ceftaroline, alongside appropriate source control. This series emphasizes the importance of periodic susceptibility reassessment during daptomycin therapy and cautions clinicians against assuming sustained susceptibility in patients with prolonged bacteremia or complex infections. Early recognition of evolving resistance and timely therapeutic adjustment may improve outcomes in this high-risk population.